ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 1, 2023, Cosmos Health Inc. (the "Company") announced the
appointment of Nikos Bardakis (54), who comes with over two decades of
international branded pharmaceutical sector experience, as the Chief Operating
Officer (COO).
As the Chief Operating Officer at Cosmos Health, Mr. Bardakis' objective will be
to bring new capabilities and processes into the organization for optimizing
operational excellence towards global commercial expansion of Cosmos' premium
products. In addition, Mr. Bardakis will focus on life science research ideas
and transforming them into product innovations that will be designed,
engineered, and marketed by Cosmos.
From January 2019 to February 2023, he served as Business Development Manager at
Cloudpharm, a research and development company focused on the discovery of
bioactive compounds and next generation food supplements, and the development of
state-of-the-art algorithms for drug repurposing and providing computational
services for drug design and development. From June 2016 to February 2023, Mr.
Bardakis was Managing Director of Life NLB, an importing and distributing
company specialized in the areas of medical devices and food supplements. From
January 2009 to February 2016, Mr. Bardakis was the National Sales Director for
Servier Hellas, a multinational pharmaceutical company specializing in the areas
of Cardiovascular, Central Nervous System and Metabolic diseases, where he led a
cross functional, client focused team comprised of sales, trade, marketing and
business development personnel, managing over 130 employees. He gained
international exposure, participating in several boards and meetings focused on
European level design and launch projects, pioneering in international
operations. From 1993 to December 2008, Mr. Bardakis was a sales representative,
area manager, full sales manager for Servier Hellas, where he last led seventy
(70) representatives and nine (9) area managers. Mr. Bardakis received a BS in
Finance from American College of Greece along with relevant studies in Natural
Sciences.
Nikos Bardakis will succeed Pavlos Ignatiades, who will assume the position of
Chief Communications Officer (CCO). As the Chief Communications Officer at
Cosmos Health, Pavlos Ignatiades' focus will be to create a consistent message
across all stakeholders that clearly communicates the Company's progress, its
vision for the future and the roadmap of how it intends to get there. Mr.
Ignatiades has been with Cosmos since its inception and was promoted to COO in
2020, where he was responsible for capital markets activities including the
Company's listing onto Nasdaq, as well as managing the Company's public
relations and investor relations departments.
A copy of the press release titled "Cosmos Health Announces the Appointment of
Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as
Chief Operating Officer" is furnished as Exhibit 99.1 to this Report.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits
Number
99.1 Press Release dated February 1, 2023 titled "Cosmos Health Announces
the Appointment of Nikos Bardakis, an Experienced Executive in the
Pharmaceutical Industry, as Chief Operating Officer"
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
2
© Edgar Online, source Glimpses